These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12684284)

  • 1. Sildenafil for pulmonary arterial hypertension: exciting, but protection required.
    Mehta S
    Chest; 2003 Apr; 123(4):989-92. PubMed ID: 12684284
    [No Abstract]   [Full Text] [Related]  

  • 2. Summary for patients. Sildenafil (Viagra) may help improve control of pulmonary hypertension.
    Ann Intern Med; 2002 Apr; 136(7):I35. PubMed ID: 11926808
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
    Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sildenafil for primary pulmonary hypertension: short and long-term symptomatic benefit.
    Jackson G; Chambers J
    Int J Clin Pract; 2002 Jun; 56(5):397-8. PubMed ID: 12137450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.
    Michelakis E; Tymchak W; Lien D; Webster L; Hashimoto K; Archer S
    Circulation; 2002 May; 105(20):2398-403. PubMed ID: 12021227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.
    Stiebellehner L; Petkov V; Vonbank K; Funk G; Schenk P; Ziesche R; Block LH
    Chest; 2003 Apr; 123(4):1293-5. PubMed ID: 12684325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
    Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
    Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.
    Miwa K; Matsubara T; Uno Y; Yasuda T; Sakata K; Tsuda T; Kanaya H
    Int Heart J; 2007 May; 48(3):417-22. PubMed ID: 17592207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of sildenafil in pulmonary artery hypertension.
    Singh TP
    Expert Rev Respir Med; 2010 Feb; 4(1):13-9. PubMed ID: 20387288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Images in congenital heart disease. Reversal of shunting in pulmonary hypertension after treatment with oral Sildenafil.
    Karatza AA; Bush A; Magee AG
    Cardiol Young; 2002 Dec; 12(6):561-2. PubMed ID: 12636006
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertension.
    Morice AH; Mulrennan S; Clark A
    Eur Respir J; 2005 Jul; 26(1):180; author reply 180-1. PubMed ID: 15994408
    [No Abstract]   [Full Text] [Related]  

  • 12. Sildenafil citrate therapy for pulmonary arterial hypertension.
    Hoeper MM; Welte T
    N Engl J Med; 2006 Mar; 354(10):1091-3; author reply 1091-3. PubMed ID: 16525151
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension.
    Keogh AM; Jabbour A; Hayward CS; Macdonald PS
    Vasc Health Risk Manag; 2008; 4(5):1111-3. PubMed ID: 19183760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of rebound pulmonary hypertension: why not sildenafil?
    Raja SG
    Anesthesiology; 2004 Dec; 101(6):1480; author reply 1481. PubMed ID: 15564966
    [No Abstract]   [Full Text] [Related]  

  • 17. Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension.
    Behzadnia N; Najafizadeh K; Sharif-Kashani B; Dameshghi DO; Shahabi P
    Heart Vessels; 2010 Jul; 25(4):313-8. PubMed ID: 20676840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.
    Porta NF; Steinhorn RH
    Clin Perinatol; 2012 Mar; 39(1):149-64. PubMed ID: 22341543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension.
    Littera R; La Nasa G; Derchi G; Cappellini MD; Chang CY; Contu L
    Blood; 2002 Aug; 100(4):1516-7. PubMed ID: 12184280
    [No Abstract]   [Full Text] [Related]  

  • 20. A new START for Sildenafil in pediatric pulmonary hypertension: reframing the dose-survival relationship in the STARTS-2 trial.
    McElhinney DB
    Circulation; 2014 May; 129(19):1905-8. PubMed ID: 24637560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.